Cantor Fitzgerald Reiterates Overweight on UniQure, Maintains $24 Price Target
Cantor Fitzgerald analyst Kristen Kluska reiterates uniQure (NASDAQ:QURE) with a Overweight and maintains $24 price target.
UniQure Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/16/2024 158.74% Cantor Fitzgerald $24 → $24 Reiterates Overweight → Overweight 07/09/2024 169.52% HC
UniQure (NASDAQ:QURE) Has Debt But No Earnings; Should You Worry?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Conagra Brands, Inc. (NYSE:CAG) fell during Thursday's session after the company reported worse-than-expected fourth-quarter sales results and issued FY25 adjusted EPS guidance below
William Blair Maintains UniQure NV(QURE.US) With Buy Rating
William Blair analyst Sami Corwin maintains $uniQure NV(QURE.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 39.8% and a total average return of -1.2% over the
Why Are UniQure Shares Surging Today?
UniQure N.V. (NASDAQ:QURE) shares are skyrocketing Wednesday following the release of promising interim data from its Phase I/II clinical trials of AMT-130, a gene therapy targeting Huntington's disease.
UniQure (QURE) Shares Soar On Positive Medical Trial News
In recent trading sessions, UniQure (NASDAQ: QURE) shares have soared by 56.15% to $10.41, bolstered by optimistic interim findings from ongoing clinical trials. The data highlights a notable slowdown in disease progression and reduced neurofilament light chain (NfL) levels, crucial markers in Huntington's disease. Long-term Therapeutic Potential and Regulatory Pathway Advancements UniQure explores a unique ...
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of SeaStar Medical Holding Corporation (NASDAQ:ICU) fell sharply during Wednesday's session after the company entered into a $10 million registered direct offering of 947,868 shares at $10.55
Express News | UniQure Shares Are Trading Higher. The Stock May Be Rising on Continued Strength After the Company Recently Announced Updated Interim Data Including up to 24 Months of Follow-up Data From 29 Treated Patients Enrolled in the Ongoing U.S. and European...
SMART Global Posts Upbeat Results, Joins Aehr Test Systems, MarineMax And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mostly higher, with the Nasdaq Composite gaining around 0.4% on Wednesday.Shares of SMART Global Holdings, Inc. (NASDAQ:SGH) rose sharply during Wednesday's session after the
Mizuho Securities Maintains UniQure NV(QURE.US) With Hold Rating
Mizuho Securities analyst Uy Ear maintains $uniQure NV(QURE.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 40.3% and a total average return of 6.3% over the
UniQure (QURE) Soars on New Huntington's Disease Study Data
Please note that uniQure, for the first time, performed a statistical analysis of clinical outcomes at 24 months for the 21 treated patients.
Guggenheim Maintains UniQure NV(QURE.US) With Buy Rating, Cuts Target Price to $28
Guggenheim analyst Debjit Chattopadhyay maintains $uniQure NV(QURE.US)$ with a buy rating, and adjusts the target price from $46 to $28.According to TipRanks data, the analyst has a success rate of 45
A Quick Look at Today's Ratings for UniQure NV(QURE.US), With a Forecast Between $14 to $25
On Jul 10, major Wall Street analysts update their ratings for $uniQure NV(QURE.US)$, with price targets ranging from $14 to $25.Wells Fargo analyst Yanan Zhu maintains with a hold rating, and
Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Wednesday.Shares of Kura Sushi USA, Inc. (NASDAQ:KRUS) fell sharply in today's pre-market trading
UniQure (QURE) Surges 76.5%: Is This an Indication of Further Gains?
uniQure (QURE Quick QuoteQURE - Free Report) shares soared 76.5% in the last trading session to close at $6.67. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 29.7% loss over the past four weeks.
Express News | Uniqure NV : Leerink Partners Raises Target Price to $26 From $25
Trending Stocks Today: Soligenix Surges 372.5%
July 9th - US stocks trending in regular trading hours.Gainers: $Soligenix(SNGX.US)$ shoots up 372.5% to $9.45 with a turnover of $1.02 billion. $180 Life Sciences(ATNF.US)$ soars 91.35% to $3.1
Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Helen of Troy Limited (NASDAQ:HELE) fell sharply during Tuesday's session after the company reported soft first-quarter earnings and lowered its FY25 guidance.Helen of Troy reported
Why UniQure Stock Is Soaring
UniQure N.V. (NASDAQ:QURE) shares are trading higher Tuesday after the company announced updated interim data from its ongoing U.S. and European Phase I/II clinical trials of AMT-130 for the